Azenta, Inc. (AZTA) Insider Trading

Last 12 months

Insiders bought $172k on the open market and sold nothing.

Net open-market

+$172k

2 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

2 / 0

executives and directors

Last open-market buy

Jul 2026

Jul 31, 2026

Get an email when AZTA's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jul 31	Ephraim Starr SVP, Gen Counsel & Secretary	Bought	335	$24.17	$8k	0.5%	Form 4
May 18	William L Cornog Director	Bought	10,000	$16.38	$164k	103%	Form 4
Sep 10, 2025	John Marotta President and CEO	SoldNo plan	316	$29.41	$9k	0.3%	Form 4
Aug 12, 2025	Olga Pirogova SVP and CHRO	SoldNo plan	1,085	$28.54	$31k	5.6%	Form 4
Aug 12, 2025	Ginger Zhou SVP and GM, Multiomics	SoldNo plan	1,085	$28.54	$31k	3.9%	Form 4
Aug 11, 2025	Lawrence Y. Lin EVP, CFO and Treasurer	Bought	2,500	$27.96	$70k	5.7%	Form 4
Jun 2, 2025	John Marotta President and CEO	Bought	1,000	$25.99	$26k	0.9%	Form 4
May 30, 2025	Alan J Malus Director	Bought	12,000	$26.65	$320k	238%	Form 4
May 16, 2025 – May 20, 2025	William L Cornog Director	Bought 3 parts	7,000	$27.13 average	$190k	37%	Form 4
Feb 3, 2025	Violetta Hughes VP, Chief Accounting Officer	SoldNo plan	317	$52.97	$17k	3.2%	Form 4
Jan 31, 2025	Ginger Zhou SVP and General Manager, Genom	Bought	417	$45.88	$19k	1.5%	Form 4
Nov 19, 2024	Olga Pirogova SVP and CHRO	SoldNo plan	548	$40.07	$22k	2.8%	Form 4
Nov 19, 2024	Violetta Hughes VP, Chief Accounting Officer	SoldNo plan	163	$40.07	$7k	1.6%	Form 4
Nov 19, 2024	Ginger Zhou SVP and General Manager, Genom	SoldNo plan	491	$40.07	$20k	1.8%	Form 4
Nov 19, 2024	David Dong Wang SVP & GM, SMS	SoldNo plan	348	$40.07	$14k	1.4%	Form 4
Nov 19, 2024	Jason Joseph SVP, General Counsel, Secy.	SoldNo plan	1,139	$40.07	$46k	1.0%	Form 4
Nov 19, 2024	Herman Cueto EVP, Chief Financial Officer	SoldNo plan	712	$40.07	$29k	2.9%	Form 4
Nov 18, 2024 – Nov 19, 2024	John Marotta President and CEO	Bought 2 parts	13,967	$39.59 average	$553k	16%	Form 4
Nov 19, 2024	Martin D Madaus Director	Bought	4,940	$40.77	$201k	200%	Form 4
Nov 18, 2024	Didier Hirsch Director	Bought	1,000	$39.50	$40k	41%	Form 4
Nov 18, 2024	William L Cornog Director	Bought	12,500	$39.60	$495k	554%	Form 4

Jul 31
Ephraim Starr
SVP, Gen Counsel & Secretary · bought 335 at $24.17
$8k
0.5% of stake
May 18
William L Cornog
Director · bought 10,000 at $16.38
$164k
103% of stake
Sep 10, 2025No plan
John Marotta
President and CEO · sold 316 at $29.41
$9k
0.3% of stake
Aug 12, 2025No plan
Olga Pirogova
SVP and CHRO · sold 1,085 at $28.54
$31k
5.6% of stake
Aug 12, 2025No plan
Ginger Zhou
SVP and GM, Multiomics · sold 1,085 at $28.54
$31k
3.9% of stake
Aug 11, 2025
Lawrence Y. Lin
EVP, CFO and Treasurer · bought 2,500 at $27.96
$70k
5.7% of stake
Jun 2, 2025
John Marotta
President and CEO · bought 1,000 at $25.99
$26k
0.9% of stake
May 30, 2025
Alan J Malus
Director · bought 12,000 at $26.65
$320k
238% of stake
May 16, 2025 – May 20, 2025
William L Cornog
Director · bought 7,000 at avg $27.13
$190k
37% of stake
Feb 3, 2025No plan
Violetta Hughes
VP, Chief Accounting Officer · sold 317 at $52.97
$17k
3.2% of stake
Jan 31, 2025
Ginger Zhou
SVP and General Manager, Genom · bought 417 at $45.88
$19k
1.5% of stake
Nov 19, 2024No plan
Olga Pirogova
SVP and CHRO · sold 548 at $40.07
$22k
2.8% of stake
Nov 19, 2024No plan
Violetta Hughes
VP, Chief Accounting Officer · sold 163 at $40.07
$7k
1.6% of stake
Nov 19, 2024No plan
Ginger Zhou
SVP and General Manager, Genom · sold 491 at $40.07
$20k
1.8% of stake
Nov 19, 2024No plan
David Dong Wang
SVP & GM, SMS · sold 348 at $40.07
$14k
1.4% of stake
Nov 19, 2024No plan
Jason Joseph
SVP, General Counsel, Secy. · sold 1,139 at $40.07
$46k
1.0% of stake
Nov 19, 2024No plan
Herman Cueto
EVP, Chief Financial Officer · sold 712 at $40.07
$29k
2.9% of stake
Nov 18, 2024 – Nov 19, 2024
John Marotta
President and CEO · bought 13,967 at avg $39.59
$553k
16% of stake
Nov 19, 2024
Martin D Madaus
Director · bought 4,940 at $40.77
$201k
200% of stake
Nov 18, 2024
Didier Hirsch
Director · bought 1,000 at $39.50
$40k
41% of stake
Nov 18, 2024
William L Cornog
Director · bought 12,500 at $39.60
$495k
554% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch AZTA, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Special Industry Machinery, NEC

VECOVeeco Instruments Inc.

CRCTCricut, Inc.

ACLSAxcelis Technologies, Inc.

ACMRAcm Research Inc.

ERIIEnergy Recovery Inc.

ASYSAmtech Systems Inc.

TRTTrio-Tech International

KRNTKornit Digital Ltd.

Spot a number that looks wrong? Check it in AZTA's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing AZTA

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.